3/28
10:09 am
syrs
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/27
07:38 am
syrs
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update [Yahoo! Finance]
Low
Report
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update [Yahoo! Finance]
3/27
07:30 am
syrs
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Medium
Report
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
3/25
07:05 am
syrs
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial [Yahoo! Finance]
Low
Report
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial [Yahoo! Finance]
3/25
07:00 am
syrs
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
Low
Report
Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
3/20
07:00 am
syrs
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
Low
Report
Syros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 2024
3/12
11:02 pm
syrs
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/29
03:07 pm
syrs
Activist investor Jeff Ubben to join Bayer’s supervisory board [FT.com - Mergermarket]
Low
Report
Activist investor Jeff Ubben to join Bayer’s supervisory board [FT.com - Mergermarket]
3/27/2024
07:30 am
SYRS
syros pharmaceuticals, inc.
MISS
Report
-8.5%
syros pharmaceuticals, inc.
11/14/2023
07:30 am
SYRS
syros pharmaceuticals, inc.
MISS
Report
1.5%
syros pharmaceuticals, inc.
8/8/2023
07:30 am
SYRS
syros pharmaceuticals, inc.
MISS
Report
1.4%
syros pharmaceuticals, inc.
5/10/2023
07:30 am
SYRS
syros pharmaceuticals, inc.
BEAT
Report
10.3%
syros pharmaceuticals, inc.
3/27
07:05 am
syrs
Form S-8 Syros Pharmaceuticals,
Medium
Report
Form S-8 Syros Pharmaceuticals,
3/27
06:50 am
syrs
Form 10-K Syros Pharmaceuticals, For: Dec 31
Medium
Report
Form 10-K Syros Pharmaceuticals, For: Dec 31
2/14
08:56 pm
syrs
Form SC 13G Syros Pharmaceuticals, Filed by: Blue Owl Capital Holdings LP
Low
Report
Form SC 13G Syros Pharmaceuticals, Filed by: Blue Owl Capital Holdings LP
2/13
08:23 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Avidity Partners Management LP
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Avidity Partners Management LP
2/13
07:02 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Ally Bridge MedAlpha Master Fund L.P.
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Ally Bridge MedAlpha Master Fund L.P.
2/13
06:59 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Bain Capital Life Sciences Fund II, L.P.
2/9
05:09 pm
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: Artal International S.C.A.
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: Artal International S.C.A.
2/7
07:09 am
syrs
Form SC 13G/A Syros Pharmaceuticals, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
Low
Report
Form SC 13G/A Syros Pharmaceuticals, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register